Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Neoplasms 6 Lung Neoplasms 6 Breast Neoplasms 4 Prostatic Neoplasms 3 Smoking Cessation 2 Recurrence 2 Neoplasm Metastasis 2 Malignant Neoplasms of Independent (Primary) Multiple Sites 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Uterine Hemorrhage 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Cessation 1 Social Stigma 1 Smoking 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Patient Participation 1 Patient Compliance 1 Ovarian Neoplasms 1 Narration 1 Multiple Myeloma 1 Metrorrhagia 1 Leukemia 1 Leiomyoma 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Health Education 1 Glioblastoma 1

Interventions

Oxaliplatin 271 Fluorouracil 268 Capecitabine 235 Leucovorin 209 Irinotecan 152 Radiotherapy 139 Bevacizumab 114 Cetuximab 82 Surgical Procedures, Operative 51 Folfox protocol 49 Neoadjuvant Therapy 45 Drug Therapy 43 Radiation 42 Chemotherapy, Adjuvant 34 Chemoradiotherapy 34 Panitumumab 27 Magnetic Resonance Spectroscopy 26 XELOX 25 Radiotherapy, Intensity-Modulated 23 Biopsy 20 Surveys and Questionnaires 18 Laparoscopy 18 Proctectomy 17 Floxuridine 17 Early Intervention, Educational 16 Nivolumab 15 Immunohistochemistry 15 Gene Expression Profiling 15 Gemcitabine 15 pembrolizumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Videotape Recording × Clear all

NCT05279287 2024-02-22

VAMIS

The Griffin Institute

GastrointestinalGenitourinary

Prostatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡